Business Context and Reporting Period
This Form 8-K reports on the results of the 2025 Annual Meeting of Stockholders for eXoZymes Inc., held on July 25, 2025. The company is incorporated in Nevada and its common stock (Symbol: EXOZ) trades on the Nasdaq Capital Market. The filing details the outcomes of five proposals submitted to shareholders, including director elections, executive compensation advisory votes, equity plan approval, and auditor ratification.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting results.
Material Changes and Voting Results
As of the record date (June 9, 2025), there were 8,367,810 shares of Common Stock outstanding. A total of 4,779,773 votes were present, representing 56.98% of the shares entitled to vote. All five proposals were approved by the shareholders:
- Proposal 1 (Director Elections): Six nominees were elected to serve until the 2026 annual meeting. Votes were overwhelmingly in favor, with minimal shares withheld for each candidate.
- Proposal 2 (Say-on-Pay): Shareholders approved the non-binding advisory resolution to approve executive compensation for the 2026 fiscal year (4,272,987 For vs. 1,801 Against).
- Proposal 3 (Say-on-Pay Frequency): Shareholders voted to hold advisory votes on executive compensation every three years (4,121,899 For Three Years).
- Proposal 4 (Equity Plan): The 2025 Performance Equity Plan was approved (4,181,189 For vs. 92,840 Against).
- Proposal 5 (Auditor Ratification): The appointment of RBSM LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified (4,779,589 For vs. 109 Against).
Guidance, Outlook, and Risks
The filing does not contain management commentary on financial guidance, future outlook, specific risks, or contingencies. The primary operational outcome noted is the establishment of a three-year cycle for future advisory votes on executive compensation based on Proposal 3 results.
Investor Verification Checklist
- Verify the final composition of the Board of Directors following the election of the six nominees.
- Review the specific terms and grant limits of the newly approved 2025 Performance Equity Plan.
- Confirm the engagement letter and audit scope with RBSM LLP for the fiscal year ending December 31, 2025.
- Monitor future filings for the next advisory vote on executive compensation, which is now scheduled for every three years.